InnoTherapy Inc (246960) — Capital Reinvestment Ratio
Latest as of June 2025:
2.80x
InnoTherapy Inc (246960) has a Capital Reinvestment Ratio of 2.80x as of June 2025, meaning it reinvests 3% of its operating cash flow (₩131.12 Million) in capital expenditures (₩367.29 Million). See 246960 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
2.80x
Capex / Operating Cash Flow
Operating Cash Flow
₩131.12 Million
KRW
Capital Expenditures
₩367.29 Million
KRW
Data as of
Jun 2025
Most recent filing
Annual Capital Reinvestment Ratio for InnoTherapy Inc (None–None)
Year-by-year Capital Reinvestment Ratio for InnoTherapy Inc from None to None. For live market cap and broader valuation context, see how much is InnoTherapy Inc worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow